ADXN Short Volume
Addex Therapeutics Ltd (ADXN) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $7.1M, listed on NASDAQ, employing roughly 3 people, carrying a beta of 2.00 to the broader market. Addex Therapeutics Ltd, a biopharmaceutical firm in a developmental phase, operates out of Switzerland, focusing on the discovery, advancement, and commercialization of small-molecule drugs targeting central nervous system (CNS) disorders. Led by Timothy Mark Dyer, public since 2020-02-12.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-08-21
- Short Volume
- 237.7K
- Total Volume
- 449.7K
- Short %
- 52.85%
- 30-Day Avg Short %
- 29.74%
Showing 30 days of FINRA short volume data for Addex Therapeutics Ltd.
Learn how short volume is reported and how to read the data →
Frequently asked ADXN short volume questions
- What is the daily ADXN short volume?
- As of Aug 21, 2026, Addex Therapeutics Ltd (ADXN) short volume is 237.7K shares against 449.7K total reported volume, or 52.85% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is ADXN short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does ADXN short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.